scispace - formally typeset
C

Camila Alexandrina Figueiredo

Researcher at Federal University of Bahia

Publications -  105
Citations -  2558

Camila Alexandrina Figueiredo is an academic researcher from Federal University of Bahia. The author has contributed to research in topics: Asthma & Atopy. The author has an hindex of 24, co-authored 89 publications receiving 2089 citations. Previous affiliations of Camila Alexandrina Figueiredo include Oswaldo Cruz Foundation & State University of Campinas.

Papers
More filters
Journal ArticleDOI

SSEA-4 identifies mesenchymal stem cells from bone marrow

TL;DR: It is reported that SSEA-4, an early embryonic glycolipid antigen commonly used as a marker for undifferentiated pluripotent human embryonic stem cells and cleavage to blastocyst stage embryos, also identifies the adult mesenchymal stem cell population.
Journal ArticleDOI

Origin and dynamics of admixture in Brazilians and its effect on the pattern of deleterious mutations

TL;DR: It is shown that ancestry-positive assortative mating permeated Brazilian history and shows that continental admixture rather than local post-Columbian history is the main and complex determinant of the individual amount of deleterious genotypes.
Journal ArticleDOI

Chronic intestinal helminth infections are associated with immune hyporesponsiveness and induction of a regulatory network.

TL;DR: Intestinal helminth infections were associated with a typical Th2 immune response profile and with the induction of immune hyporesponsiveness that was associated with greater frequencies of the production of spontaneous IL-10, especially among coinfected and chronically infected children.
Journal ArticleDOI

Effects produced by Royal Jelly on haematopoiesis: relation with host resistance against Ehrlich ascites tumour challenge.

TL;DR: It is demonstrated that RJ prevented the myelosupression induced by the temporal evolution of the tumour and abrogated the splenic haematopoiesis observed in EAT-bearing mice, pointing to RJ as a promising modifier of biological response leading to myeloprotection and antitumour activity.